Search research articles
Contact Us
Filters
Showing results (71-80 of 86) with videos related to
Page
of 9
Sort By:
Eye (London, England)
|
August 18, 1999
Dinucleotide repeat polymorphisms in EDN1 and NOS3 are not associated with severe diabetic retinopathy in type 1 or type 2 diabetes
K M Warpeha, F Ah-Fat, S Harding, et al.
Eye (London, England)
|
September 9, 2017
An overview of the clinical applications of optical coherence tomography angiography
A C S Tan, G S Tan, A K Denniston, et al.
Health Technology Assessment (Winchester, England)
|
June 3, 2008
A preliminary model-based assessment of the cost-utility of a screening programme for early age-related macular degeneration
J Karnon, C Czoski-Murray, K Smith, et al.
Health Technology Assessment (Winchester, England)
|
February 22, 2012
Verteporfin photodynamic therapy for neovascular age-related macular degeneration: cohort study for the UK
B C Reeves, S P Harding, J Langham, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
March 24, 2016
Increasing fruit and vegetable intake has no effect on retinal vessel caliber in adults at high risk of developing cardiovascular disease
C T McEvoy, I R Wallace, L L Hamill, et al.
The British Journal of Ophthalmology
|
July 19, 2005
Visual functioning and quality of life in the SubFoveal Radiotherapy Study (SFRADS): SFRADS report 2
M R Stevenson, P M Hart, U Chakravarthy, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)
|
August 1, 2002
Visual outcomes in the subfoveal radiotherapy study: a randomized controlled trial of teletherapy for age-related macular degeneration
P M Hart, U Chakravarthy, G Mackenzie, et al.
The British Journal of Ophthalmology
|
August 25, 2006
Evolving European guidance on the medical management of neovascular age related macular degeneration
U Chakravarthy, G Soubrane, F Bandello, et al.
Eye (London, England)
|
October 10, 2015
The design and implementation of a study to investigate the effectiveness of community vs hospital eye service follow-up for patients with neovascular age-related macular degeneration with quiescent disease
J Taylor, L J Scott, C A Rogers, et al.
BMJ Open
|
November 1, 2016
Cost-effectiveness of community versus hospital eye service follow-up for patients with quiescent treated age-related macular degeneration alongside the ECHoES randomised trial
M Violato, H Dakin, U Chakravarthy, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 86) with videos related to
Sort By:
Page
of 9
Eye (London, England)
|
August 18, 1999
Dinucleotide repeat polymorphisms in EDN1 and NOS3 are not associated with severe diabetic retinopathy in type 1 or type 2 diabetes
K M Warpeha, F Ah-Fat, S Harding, et al.
Eye (London, England)
|
September 9, 2017
An overview of the clinical applications of optical coherence tomography angiography
A C S Tan, G S Tan, A K Denniston, et al.
Health Technology Assessment (Winchester, England)
|
June 3, 2008
A preliminary model-based assessment of the cost-utility of a screening programme for early age-related macular degeneration
J Karnon, C Czoski-Murray, K Smith, et al.
Health Technology Assessment (Winchester, England)
|
February 22, 2012
Verteporfin photodynamic therapy for neovascular age-related macular degeneration: cohort study for the UK
B C Reeves, S P Harding, J Langham, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
March 24, 2016
Increasing fruit and vegetable intake has no effect on retinal vessel caliber in adults at high risk of developing cardiovascular disease
C T McEvoy, I R Wallace, L L Hamill, et al.
The British Journal of Ophthalmology
|
July 19, 2005
Visual functioning and quality of life in the SubFoveal Radiotherapy Study (SFRADS): SFRADS report 2
M R Stevenson, P M Hart, U Chakravarthy, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)
|
August 1, 2002
Visual outcomes in the subfoveal radiotherapy study: a randomized controlled trial of teletherapy for age-related macular degeneration
P M Hart, U Chakravarthy, G Mackenzie, et al.
The British Journal of Ophthalmology
|
August 25, 2006
Evolving European guidance on the medical management of neovascular age related macular degeneration
U Chakravarthy, G Soubrane, F Bandello, et al.
Eye (London, England)
|
October 10, 2015
The design and implementation of a study to investigate the effectiveness of community vs hospital eye service follow-up for patients with neovascular age-related macular degeneration with quiescent disease
J Taylor, L J Scott, C A Rogers, et al.
BMJ Open
|
November 1, 2016
Cost-effectiveness of community versus hospital eye service follow-up for patients with quiescent treated age-related macular degeneration alongside the ECHoES randomised trial
M Violato, H Dakin, U Chakravarthy, et al.
Page
of 9